CXC chemokines in angiogenesis
Top Cited Papers
- 19 July 2005
- journal article
- review article
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 16 (6) , 593-609
- https://doi.org/10.1016/j.cytogfr.2005.04.007
Abstract
No abstract availableKeywords
This publication has 117 references indexed in Scilit:
- NF‐κB activity blockade impairs the angiogenic potential of human pancreatic cancer cellsInternational Journal of Cancer, 2003
- Kaposi's Sarcoma-Like Tumors in a Human Herpesvirus 8 ORF74 Transgenic MouseJournal of Virology, 2003
- NF-κB, chemokine gene transcription and tumour growthNature Reviews Immunology, 2002
- Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localizationEuropean Journal of Immunology, 1998
- Human Interferon-γ–inducible Protein 10 (IP-10) Inhibits Constitutive Signaling of Kaposi's Sarcoma–associated Herpesvirus G Protein–coupled ReceptorThe Journal of Experimental Medicine, 1998
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Bronchial vascular congestion and angiogenesisEuropean Respiratory Journal, 1997
- The Functional Role of the ELR Motif in CXC Chemokine-mediated AngiogenesisJournal of Biological Chemistry, 1995
- Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma.The Journal of Experimental Medicine, 1994
- Platelet factor 4 blocks the binding of basic fibroblast growth factor to the receptor and inhibits the spontaneous migration of vascular endothelial cellsBiochemical and Biophysical Research Communications, 1990